Use of cisplatin without desensitization after carboplatin hypersensitivity reaction in epithelial ovarian and primary peritoneal cancer
Megan B. Callahan(University of Virginia), Amir A. Jazaeri(The University of Texas MD Anderson Cancer Center), Rebecca L. Stone(System Biosciences (United States)), Jason A. Lachance(University of Virginia), Laurel W. Rice(University of Virginia), Julie J. Kelsey(University of Virginia)
Cited by 51
Related Papers
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
|Proceedings of the National Academy of Sciences|2003|2k
Paraneoplastic Thrombocytosis in Ovarian Cancer
|New England Journal of Medicine|2012|822
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
|Nature Medicine|2023|508
Gene Expression Profiles of BRCA1-Linked, BRCA2-Linked, and Sporadic Ovarian Cancers
|JNCI Journal of the National Cancer Institute|2002|285